These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

777 related articles for article (PubMed ID: 31112383)

  • 1. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    ; Moss M; Huang DT; Brower RG; Ferguson ND; Ginde AA; Gong MN; Grissom CK; Gundel S; Hayden D; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Khan A; Liu KD; Talmor D; Thompson BT; Ulysse CA; Yealy DM; Angus DC
    N Engl J Med; 2019 May; 380(21):1997-2008. PubMed ID: 31112383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular blockers in early acute respiratory distress syndrome.
    Papazian L; Forel JM; Gacouin A; Penot-Ragon C; Perrin G; Loundou A; Jaber S; Arnal JM; Perez D; Seghboyan JM; Constantin JM; Courant P; Lefrant JY; Guérin C; Prat G; Morange S; Roch A;
    N Engl J Med; 2010 Sep; 363(12):1107-16. PubMed ID: 20843245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisatracurium Continuous Infusion Versus No Neuromuscular Blockade for Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation.
    Kressin C; Thompson Bastin M; Ather A; Gopinath A; Srour H; Schadler A; Pandya K
    J Clin Pharmacol; 2021 Nov; 61(11):1415-1420. PubMed ID: 34180067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
    Needham CJ; Brindley PG
    Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome.
    Sottile PD; Kiser TH; Burnham EL; Ho PM; Allen RR; Vandivier RW; Moss M;
    Am J Respir Crit Care Med; 2018 Apr; 197(7):897-904. PubMed ID: 29241014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Sedation in Patients Who Receive Neuromuscular Blocking Agent Infusions for Treatment of Acute Respiratory Distress Syndrome-A Retrospective Cohort Study From a New England Health Care Network.
    Wongtangman K; Grabitz SD; Hammer M; Wachtendorf LJ; Xu X; Schaefer MS; Fassbender P; Santer P; Kassis EB; Talmor D; Eikermann M;
    Crit Care Med; 2021 Jul; 49(7):1137-1148. PubMed ID: 33710031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome.
    Huang DT; Angus DC; Moss M; Thompson BT; Ferguson ND; Ginde A; Gong MN; Gundel S; Hayden DL; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Liu KD; Talmor DS; Yealy DM;
    Ann Am Thorac Soc; 2017 Jan; 14(1):124-133. PubMed ID: 27779896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Titrating Positive End-Expiratory Pressure (PEEP) With an Esophageal Pressure-Guided Strategy vs an Empirical High PEEP-Fio2 Strategy on Death and Days Free From Mechanical Ventilation Among Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.
    Beitler JR; Sarge T; Banner-Goodspeed VM; Gong MN; Cook D; Novack V; Loring SH; Talmor D;
    JAMA; 2019 Mar; 321(9):846-857. PubMed ID: 30776290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paediatric Acute Respiratory Distress Syndrome Neuromuscular Blockade study (PAN-study): a phase IV randomised controlled trial of early neuromuscular blockade in moderate-to-severe paediatric acute respiratory distress syndrome.
    Rudolph MW; Slager S; Burgerhof JGM; van Woensel JBM; Alffenaar JC; Wösten-van Asperen RM; de Hoog M; IJland MM; Kneyber MCJ;
    Trials; 2022 Jan; 23(1):96. PubMed ID: 35101098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Train-of-Four Values and Gas Exchange Indices in Moderate to Severe Acute Respiratory Distress Syndrome.
    Groetzinger LM; Rivosecchi RM; Kane-Gill SL; Donahoe MP
    Ann Pharmacother; 2016 Dec; 50(12):1009-1015. PubMed ID: 27511813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Cisatracurium Versus Atracurium in Early ARDS.
    Moore L; Kramer CJ; Delcoix-Lopes S; Modrykamien AM
    Respir Care; 2017 Jul; 62(7):947-952. PubMed ID: 28351905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome.
    Guervilly C; Bisbal M; Forel JM; Mechati M; Lehingue S; Bourenne J; Perrin G; Rambaud R; Adda M; Hraiech S; Marchi E; Roch A; Gainnier M; Papazian L
    Intensive Care Med; 2017 Mar; 43(3):408-418. PubMed ID: 28013329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular Blockade Monitoring in Acute Respiratory Distress Syndrome: Randomized Controlled Trial of Clinical Assessment Alone or With Peripheral Nerve Stimulation.
    Rezaiguia-Delclaux S; Laverdure F; Genty T; Imbert A; Pilorge C; Amaru P; Sarfati C; Stéphan F
    Anesth Analg; 2021 Apr; 132(4):1051-1059. PubMed ID: 33002927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Alhazzani W; Alshahrani M; Jaeschke R; Forel JM; Papazian L; Sevransky J; Meade MO
    Crit Care; 2013 Mar; 17(2):R43. PubMed ID: 23497608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Fixed Dosing vs Train of Four Titration of Cisatracurium in COVID-19 ARDS Patients.
    Banerjee O; Elefritz JL; Doepker BA; Atyia SA; Brummel NE; Smith RM; Handley D; Cape KM
    J Pharm Pract; 2024 Oct; 37(5):1082-1090. PubMed ID: 38087423
    [No Abstract]   [Full Text] [Related]  

  • 16. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.
    Villar J; Ferrando C; Martínez D; Ambrós A; Muñoz T; Soler JA; Aguilar G; Alba F; González-Higueras E; Conesa LA; Martín-Rodríguez C; Díaz-Domínguez FJ; Serna-Grande P; Rivas R; Ferreres J; Belda J; Capilla L; Tallet A; Añón JM; Fernández RL; González-Martín JM;
    Lancet Respir Med; 2020 Mar; 8(3):267-276. PubMed ID: 32043986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients.
    Newman PJ; Quinn AC; Grounds RM; Hunter JM; Boyd AH; Eastwood NB; Pollard BJ; Pearson AJ; Harper NJ; Beale RJ; Sutjarittam M; Elliot JM; Bion JF
    Crit Care Med; 1997 Jul; 25(7):1139-42. PubMed ID: 9233738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended neuromuscular blockade in acute respiratory distress syndrome does not increase mortality.
    Barmparas G; Dhillon NK; Tatum JM; Patel K; Thomsen GM; Mason R; Margulies DR; Ley EJ
    J Surg Res; 2018 Nov; 231():434-440. PubMed ID: 30278965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compared efficacy and tolerance of the neuromuscular blockade induced by brand-name (Nimbex®) and generic (Cisatrex®) of cisatracurium in mechanically ventilated critically ill patients: a crossover double-blind randomized study.
    Fraj N; Meddeb K; Azouzi A; Romdhani S; Saad HB; Boussarsar M
    Pan Afr Med J; 2020; 37():346. PubMed ID: 33738034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.
    Ranieri VM; Pettilä V; Karvonen MK; Jalkanen J; Nightingale P; Brealey D; Mancebo J; Ferrer R; Mercat A; Patroniti N; Quintel M; Vincent JL; Okkonen M; Meziani F; Bellani G; MacCallum N; Creteur J; Kluge S; Artigas-Raventos A; Maksimow M; Piippo I; Elima K; Jalkanen S; Jalkanen M; Bellingan G;
    JAMA; 2020 Feb; 323(8):725-733. PubMed ID: 32065831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.